Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice

被引:55
|
作者
Eckert, A
Schindowski, K
Leutner, S
Luckhaus, C
Touchet, N
Czech, C
Müller, WE
机构
[1] Univ Frankfurt, Dept Pharmacol, Bioctr, D-60439 Frankfurt, Germany
[2] Aventis Pharma, Res & Dev, F-94403 Vitry, France
关键词
Alzheimer's disease; presenilin-1; cell death; calcium; oxidative stress; lymphocytes; cytochrome c;
D O I
10.1006/nbdi.2000.0378
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene. Expression of PS1 mutations in cell culture systems and in primary neurons from transgenic mice increases their vulnerability to cell death. Interestingly, enhanced vulnerability to cell death has also been demonstrated for peripheral lymphocytes from AD patients. We now report that lymphocytes from PS1 mutant transgenic mice show a similar hypersensitivity to cell death as do peripheral cells from AD patients and several cell culture systems expressing PS1 mutations. The cell death-enhancing action of mutant PS1 was associated with increased production of reactive oxygen species and altered calcium regulation, but not with changes of mitochondrial cytochrome c. Our study further emphasizes the pathogenic role of mutant PS1 and may provide the fundamental basis for new efforts to close the gap between studies using neuronal cell lines transfected with mutant PS1, neurons from transgenic animals, and peripheral cells from AD patients. (C) 2001 Academic Press.
引用
收藏
页码:331 / 342
页数:12
相关论文
共 50 条
  • [1] Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer’s disease
    Adele Woodhouse
    Claire E. Shepherd
    Anna Sokolova
    Victoria L. Carroll
    Anna E. King
    Glenda M. Halliday
    Tracey C. Dickson
    James C. Vickers
    Acta Neuropathologica, 2009, 117
  • [2] Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease
    Woodhouse, Adele
    Shepherd, Claire E.
    Sokolova, Anna
    Carroll, Victoria L.
    King, Anna E.
    Halliday, Glenda M.
    Dickson, Tracey C.
    Vickers, James C.
    ACTA NEUROPATHOLOGICA, 2009, 117 (01) : 19 - 29
  • [3] Presenilin-1 polymorphism and Alzheimer's disease
    Higuchi, S
    Muramatsu, T
    Matsushita, S
    Arai, H
    Sasaki, H
    LANCET, 1996, 347 (9009): : 1186 - 1186
  • [4] Presenilin-1 mutations in Alzheimer's disease
    C. Russo
    G. Schettini
    T. C. Saido
    C. Hulette
    C. Lippa
    L. Lannfelt
    B. Ghetti
    P. Gambetti
    M. Tabaton
    J. K. Teller
    Nature, 2000, 405 : 531 - 532
  • [5] Presenilin-1 polymorphism and Alzheimer's disease
    Scott, WK
    Roses, AD
    Haines, JL
    PericakVance, MA
    LANCET, 1996, 347 (9014): : 1560 - 1560
  • [6] Presenilin-1 polymorphism and Alzheimer's disease
    Owen, MJ
    Kehoe, P
    Williams, J
    LANCET, 1996, 348 (9024): : 414 - 414
  • [7] Presenilin-1 mutations and Alzheimer's disease
    Kelleher, Raymond J., III
    Shen, Jie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (04) : 629 - 631
  • [8] Plaque pathology in presenilin-1 Alzheimer's disease
    Shepherd, C
    Gregory, G
    McCann, H
    Halliday, G
    Kwok, J
    Schofield, P
    Kril, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S220 - S220
  • [9] Presenilin-1 gene mutations in Alzheimer's disease
    Mann, DMA
    BRAIN PATHOLOGY, 2000, 10 (04) : 713 - 713
  • [10] Neurobiology - Presenilin-1 mutations in Alzheimer's disease
    Russo, C
    Schettini, G
    Saido, TC
    Hulette, C
    Lippall, C
    Lannfelt, L
    Ghetti, B
    Gambetti, P
    Tabaton, M
    Teller, JK
    NATURE, 2000, 405 (6786) : 531 - 532